OnKure Therapeutics, Inc.
General ticker "OKUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $55.3M (TTM average)
OnKure Therapeutics, Inc. follows the US Stock Market performance with the rate: 25.2%.
Estimated limits based on current volatility of 4.2%: low 4.07$, high 4.42$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.12$, 6.57$]
- 2026-12-31 to 2027-12-31 estimated range: [1.80$, 5.61$]
Short-term OKUR quotes
Long-term OKUR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $36.93MM | $54.39MM | $62.95MM |
| Operating Income | $-36.93MM | $-54.39MM | $-62.95MM |
| Non-Operating Income | $1.62MM | $1.71MM | $3.43MM |
| Interest Expense | $0.00MM | $0.30MM | $0.00MM |
| R&D Expense | $32.12MM | $43.80MM | $48.26MM |
| Income(Loss) | $-35.31MM | $-52.67MM | $-59.52MM |
| Profit(Loss)* | $-35.31MM | $-52.67MM | $-59.52MM |
| Stockholders Equity | $-101.84MM | $103.83MM | $56.18MM |
| Assets | $35.73MM | $114.91MM | $62.12MM |
| Operating Cash Flow | $-34.55MM | $-51.12MM | $-51.83MM |
| Capital expenditure | $0.25MM | $0.05MM | $0.05MM |
| Investing Cash Flow | $-0.25MM | $15.87MM | $-0.05MM |
| Financing Cash Flow | $53.12MM | $116.13MM | $0.16MM |
| Earnings Per Share** | $-2.65 | $-3.95 | $-4.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.